Search results for "infant"

showing 10 items of 3339 documents

Mapping child growth failure across low- and middle-income countries

2020

Childhood malnutrition is associated with high morbidity and mortality globally1. Undernourished children are more likely to experience cognitive, physical, and metabolic developmental impairments that can lead to later cardiovascular disease, reduced intellectual ability and school attainment, and reduced economic productivity in adulthood2. Child growth failure (CGF), expressed as stunting, wasting, and underweight in children under five years of age (0–59 months), is a specific subset of undernutrition characterized by insufficient height or weight against age-specific growth reference standards3–5. The prevalence of stunting, wasting, or underweight in children under five is the proport…

Time FactorsDevelopmental DisabilitiesPsychological interventionDistribution (economics)0302 clinical medicinerisk factors030212 general & internal medicineSigns and symptomsWastingChildrenLocal Burden of Disease Child Growth Failure Collaborators2. Zero hungerMultidisciplinaryUnder-five1. No povertyPublic Health Global Health Social Medicine and EpidemiologyA900 Others in Medicine and Dentistry3. Good healthMultidisciplinary SciencesGeographyChild PreschoolScience & Technology - Other TopicsHEALTHUnderweightmedicine.symptomsocial sciencesInfantsAFRICAmedicine.medical_specialtyGeneral Science & TechnologyRJDeveloping countryNutritional StatusWorld Health OrganizationChild Nutrition DisordersArticleSocial sciencesMalnutrició03 medical and health sciencesAGEEnvironmental healthmedicineMortalitatHumansMortalityDeveloping CountriesScience & Technologybusiness.industryPublic healthMORTALITYBody WeightMalnutritionInfant NewbornInfantChild growth failuremedicine.diseasesigns and symptomsMalnutritionFolkhälsovetenskap global hälsa socialmedicin och epidemiologiRisk factorsWEIGHTbusinessRA030217 neurology & neurosurgery
researchProduct

IMMUNOGENICITY OF AN ACELLULAR PERTUSSIS VACCINE COMPOSED OF GENETICALLY INACTIVATED PERTUSSIS TOXIN COMBINED WITH FILAMENTOUS HEMAGGLUTININ AND PERT…

1993

We studied the immunogenicity of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin (PT-9K/129G), filamentous haemagglutinin, and a 69-kilodalton protein, pertactin, in 30 children aged 12 to 24 months and in 80 infants aged 2 to 4 months. A significant increase of the neutralizing titer and of the titers against pertussis toxin, filamentous hemagglutinin, and pertactin, as determined by enzyme-linked immunosorbent assay, was achieved after three doses of vaccine in all the children; a significant increase of these antibody titers was obtained in 100%, 96.1%, 93.5%, and 98.7% of the infants, respectively.

Time FactorsFilamentous haemagglutinin adhesinPertussis toxincomplex mixturesBordetella pertussisMicrobiologyNeutralization TestsHumansMedicineVirulence Factors BordetellaAdhesins BacterialImmunization ScheduleWhooping coughPertussis VaccineAntigens Bacterialbusiness.industryImmunogenicitypertussisAntibody titerInfantmedicine.diseaseAntibodies BacterialVirologyVaccinationTiterHemagglutininsPertussis ToxinVaccines InactivatedChild PreschoolImmunoglobulin GPediatrics Perinatology and Child HealthDrug EvaluationPertactinbusinessVaccinepertussis; VaccineBacterial Outer Membrane Proteins
researchProduct

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety an…

1995

Objective: To evaluate the safety and the immunogenicity of a booster dose of recombinant acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP, Biocine SpA) in 15- to 21-month-old children primed in infancy with either whole-cell diphtheria-tetanus-pertussis (DTwP) vaccine or DTaP vaccine. Design: Open-label second phase of a double-masked, controlled trail, with masked analysis of serum samples. Participants and setting: Three hundred fifty children, 15 to 21 months of age, who had been primed at 2, 4, and 6 months of age with either three doses of DTaP vaccine (n = 173) or DTwP vaccine (n = 177). The children were enrolled in eight vaccination centers in Italy. I…

Time FactorsWhooping CoughImmunization SecondaryEnzyme-Linked Immunosorbent AssayBooster dosecomplex mixturesBordetella pertussisDouble-Blind MethodmedicineHumansVirulence Factors BordetellaDiphtheria-Tetanus-Pertussis VaccineWhooping coughPertussis VaccineVaccines SyntheticTetanusbusiness.industryDiphtheriaToxoidAntibody titerInfantmedicine.diseaseAntibodies BacterialVirologyVACCINE pertussisVaccinationPertussis ToxinPediatrics Perinatology and Child HealthImmunologyPertussis vaccinebusinessFollow-Up Studiesmedicine.drug
researchProduct

Evaluation of Mycotoxins in Infant Breast Milk and Infant Food, Reviewing the Literature Data

2021

In this review, an analysis focusing on mycotoxin determination in infant breast milk and infant food has been summarised for the last fifteen years of research focused on the intended population group of 1–9 months. The objective was to know the level of exposure of the child population to an estimated daily intake (EDI) of mycotoxins from the consumption of habitual foods. The EDI was compared with the tolerable daily intake (TDI) established by EFSA to estimate risk. In breast milk, the high prevalence and levels were for samples from Africa (Egypt and Tanzania) with aflatoxin M1 (1.9 μg/L and 10%), and Asia (Iran) with ochratoxin-A (7.3 μg/L and 100%). In infant formulas, high incidence…

Tolerable daily intakeAflatoxinHealth Toxicology and MutagenesisPopulationReviewBreast milkToxicology01 natural sciencesRisk AssessmentmycotoxinPatulinToxicologyDietary Exposurechemistry.chemical_compound0404 agricultural biotechnologyMedicineHumanseducationMycotoxinestimated daily intakeeducation.field_of_studyMilk Humanbusiness.industryIncidence (epidemiology)010401 analytical chemistryRfood and beveragesInfantinfant formula04 agricultural and veterinary sciencesMycotoxins040401 food science0104 chemical scienceschemistryInfant formulainfant cereals baby foodFruitMedicinebreast milkInfant FoodbusinessEdible GrainToxins
researchProduct

Infant exposure of perfluorinated compounds: Levels in breast milk and commercial baby food

2010

In this study, an analytical method to determine six previous termperfluorinatednext term compounds (PFCs) based on alkaline digestion and solid phase extraction (SPE) followed by liquid chromatography-quadrupole-linear ion trap mass spectrometry (LC-QqLIT-MS) was validated for the analysis of human breast milk, milk previous terminfantnext term formulas and cereals baby food. The average recoveries of the different matrices were in general higher than 70% with a relative standard deviation (RSD) lower than 21% and method limits of detection (MLOD) ranging from 1.2 to 362 ng/L for the different compounds and matrices. The method was applied to investigate the occurrence of PFCs in 20 sample…

Tolerable daily intakeBreast milkBreast milkBaby foodchemistry.chemical_compoundTandem Mass SpectrometryPerfluorinatednext term chemicalsHumansIngestionSolid phase extractionFood scienceprevious termInfantnext term formulaslcsh:Environmental sciencesGeneral Environmental Sciencelcsh:GE1-350FluorocarbonsChromatographyMilk HumanChemistrySolid Phase ExtractionInfantInfant exposurefood and beveragesEnvironmental ExposureInfant formulaPerfluorooctanoic acidEnvironmental PollutantsFemaleInfant FoodCaprylatesLC-QLIT-MSBaby foodsChromatography LiquidEnvironmental Monitoring
researchProduct

Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

2019

Aim The adequate dosing of topiramate in neonates undergoing therapeutic hypothermia has not been established. The aim of this study was to design a dosing schedule capable of providing topiramate serum concentrations within the accepted therapeutic range. Methods Neonates (n = 52) with hypoxic ischaemic encephalopathy and subjected to therapeutic hypothermia were dosed with topiramate, 5 mg/kg on day one and 3 mg/kg on days two to five, to decrease seizure events. A total of 451 topiramate serum concentrations obtained in the patients were used to develop a population pharmacokinetic model using a non-linear mixed-effects modelling approach. Results A one-compartment model with first-order…

TopiramatePopulationHypoxic ischaemic encephalopathyHypoxic Ischemic Encephalopathy03 medical and health sciences0302 clinical medicineTherapeutic indexPharmacokineticsHypothermia InducedSeizuresTopiramate030225 pediatricsMedicineHumans030212 general & internal medicineDosingeducationeducation.field_of_studybusiness.industryInfant NewbornGeneral MedicineHypothermiaAnesthesiaPediatrics Perinatology and Child HealthHypoxia-Ischemia Brainmedicine.symptombusinessmedicine.drugActa paediatrica (Oslo, Norway : 1992)REFERENCES
researchProduct

Topiramate and Metabolic Acidosis in Infants and Toddlers

2002

Summary:  Purpose: Topiramate (TPM) inhibits carbonic anhydrase, with metabolic acidosis as a possible side effect, although this has been reported in only two adult cases. We investigated the acid–base metabolism in infants and toddlers treated with TPM. Methods: Nine infants and toddlers aged 5 months to 2.3 years (median, 6 months) were treated with TPM at maximal doses of 8.2–26 mg/kg/day (median, 11 mg/kg/day). The maximal TPM dose was achieved after 8–35 days (median, 17 days). TPM was given in addition to other antiepileptic drugs (AEDs) in five cases and as a sole AED in four patients with refractory epilepsy resistant to multiple AEDs. The diagnoses were infantile spasms (n = 5), e…

Topiramatemedicine.medical_specialtyEpilepsia partialis continuaFructoseAcid–base homeostasisDrug Administration ScheduleTopiramateHyperventilationmedicineHumansAcidosisAcid-Base EquilibriumEpilepsyDose-Response Relationship Drugbusiness.industryMetabolic disorderAge FactorsInfantMetabolic acidosisHydrogen-Ion Concentrationmedicine.diseaseSurgeryBicarbonatesTreatment OutcomeNeurologyChild PreschoolAnesthesiaAnticonvulsantsBase excessNeurology (clinical)Blood Gas Analysismedicine.symptomAcidosisbusinessFollow-Up Studiesmedicine.drugEpilepsia
researchProduct

Congenital hypothyroidism: A 2020-2021 consensus guidelines update-An ENDO-European Reference Network initiative endorsed by the European Society for…

2021

Background: An ENDO-European Reference Network (ERN) initiative was launched that was endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology with 22 participants from the ENDO-ERN and the two societies. The aim was to update the practice guidelines for the diagnosis and management of congenital hypothyroidism (CH). A systematic literature search was conducted to identify key articles on neonatal screening, diagnosis, and management of primary and central CH. The evidence-based guidelines were graded with the Grading of Recommendations, Assessment, Development and Evaluation system, describing both the strength of recommendations and the quali…

Transition to Adult Caremedicine.medical_specialtyConsensusdyshormonogenesisPediatric endocrinologyEndocrinology Diabetes and MetabolismLevothyroxine030209 endocrinology & metabolismHarmonization03 medical and health sciences0302 clinical medicineEndocrinologyNeonatal ScreeningPredictive Value of TestsRisk FactorsInternal medicineEpidemiologyCentral hypothyroidismneonatal screeningHumansMedicineguidelinesGrading (education)thyroid dysgenesisCongenital hypothyroidism guidelines pediatric endocrinologycongenital hypothyroifidm consensus guideline EndoERNEvidence-Based Medicinebusiness.industryInfant Newborncentral hypothyroidismcongenital hypothyroidismPrognosismedicine.diseaseCongenital hypothyroidismBenchmarkingEndocrinology030220 oncology & carcinogenesisFamily medicineEtiologySpecial Articlesbusinessmedicine.drugYearbook of Paediatric Endocrinology
researchProduct

Habilidades matemáticas tempranas en niños chilenos con Trastorno del Desarrollo del Lenguaje: Un estudio comparativo

2021

En las últimas décadas se ha incrementado el interés de las investigaciones respecto a las dificultades académicas que presentan los niños con Trastorno del Desarrollo del Lenguaje (TDL). No obstante, su relación con las habilidades matemáticas es una de las menos estudiadas. El objetivo de este estudio consistió en determinar si existen diferencias relevantes entre las habilidades matemáticas tempranas de niños con TDL y con desarrollo típico (DT). Participaron 78 niños de 4 a 7 años 11 meses de edad, pertenecientes a colegios con programas de integración escolar de Santiago de Chile. Se conformó un grupo de 44 niños con TDL y un grupo de 34 con DT. Se establecieron comparaciones del rendi…

Trastorno del Desarrollo del Lenguaje (TDL)MatemáticasSpecificLanguage Impairment (SLI)P1-1091matemáticasLanguage and Linguistics030507 speech-language pathology & audiology03 medical and health sciencesSpeech and HearingTrastorns de la parla en els infants0501 psychology and cognitive scienceshabilidades matemáticas tempranasPhilology. LinguisticsDesarrollo Típico (DT)LogopediaHabilidades matemáticas tempranasEarly math skillsLanguage and Literature05 social sciencesPOtorhinolaryngologyRF1-547Typically Developing (TD)0305 other medical scienceTrastorno Específico del Lenguaje (TEL)MathematicsMatemàtica Aptitud per a laDevelopmental Language Disorder (DLD)050104 developmental & child psychology
researchProduct

Programa de condicionamiento para instauración del control del babeo

2001

Trastornos del desarrolloParalisis Cerebral Infantil:PSICOLOGÍA [UNESCO]UNESCO::PSICOLOGÍAUNESCO::PSICOLOGÍA::Psicología del niño y del adolescente::OtrasPsicologia Evolutiva y de la Educación:PSICOLOGÍA::Psicología del niño y del adolescente::Otras [UNESCO]
researchProduct